Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesMRIResting-state fMRI analysis reveals impact of blast exposuresA study of active and veteran U.S. special operations forces cohorts confirms how regions of the brain become altered.MRIMRI radiomics model predicts risk in women with DCISUltrasoundAIUM: Ob/gyn gaining ground on radiology in gynecologic ultrasoundUltrasoundAIUM: POCUS residency tracks improve skills for family med specialistsSponsor ContentElevate your patient's care with the capabilities of Cardiac PET/CT
